Aquestive Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $13,015 | $12,807 | $10,003 | $8,720 |
Gross Profit | 7,179 | 8,301 | 5,442 | 5,068 |
EBITDA | -28,709 | -11,034 | -9,132 | -15,763 |
EBIT | -28,839 | -11,173 | -9,272 | -18,652 |
Net Income | -31,860 | -15,446 | -13,548 | -22,930 |
Net Change In Cash | 13,015 | 12,807 | 10,003 | 8,720 |
Free Cash Flow | -8,554 | -12,884 | -8,021 | -23,535 |
Cash | 121,169 | 129,062 | 60,536 | 68,657 |
Basic Shares | 121,966 | 110,584 | 99,326 | 95,497 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $44,545 | $57,561 | $50,583 | $47,680 |
Gross Profit | 25,990 | 39,689 | 29,752 | 28,294 |
EBITDA | -70,492 | -26,616 | 1,182 | -39,580 |
EBIT | -71,051 | -27,334 | -163 | -41,967 |
Net Income | -83,784 | -44,137 | -7,870 | -54,410 |
Net Change In Cash | 44,545 | 57,561 | 50,583 | 47,680 |
Free Cash Flow | -52,994 | -35,918 | -7,375 | -12,313 |
Cash | 121,169 | 71,546 | 23,872 | 27,273 |
Basic Shares | 121,966 | 86,726 | 61,255 | 48,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.26 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.14 |